Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerstoft

Showing results (141-150 of 198) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|March 18, 2000
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, S Dam Nielsen, et al.
The Journal of Infectious Diseases|August 19, 2000
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infectionT L Katzenstein, O Kirk, C Pedersen, et al.
AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.
HIV Medicine|August 31, 2018
HIV infection is independently associated with a higher concentration of alpha-1 antitrypsinR F Thudium, J Lundgren, T Benfield, et al.
Ugeskrift for Laeger|March 31, 1986
[Clinical neurological picture of Danish patients with AIDS]F Boesen, B Brun, J Gaub, et al.
Scandinavian Journal of Infectious Diseases|November 27, 1999
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort studyS Jensen-Fangel, O Kirk, L Larsen, et al.
The Journal of Infectious Diseases|October 21, 1998
Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretionA K Iversen, L Fugger, J Eugen-Olsen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy GroupJ Gerstoft, H Melander, J N Bruun, et al.
The Journal of Infectious Diseases|May 21, 1998
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretionsA K Iversen, A R Larsen, T Jensen, et al.
AIDS (London, England)|August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNAN Clumeck, F Goebel, W Rozenbaum, et al.
Pageof 20

Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|March 18, 2000
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, S Dam Nielsen, et al.
The Journal of Infectious Diseases|August 19, 2000
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infectionT L Katzenstein, O Kirk, C Pedersen, et al.
AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.
HIV Medicine|August 31, 2018
HIV infection is independently associated with a higher concentration of alpha-1 antitrypsinR F Thudium, J Lundgren, T Benfield, et al.
Ugeskrift for Laeger|March 31, 1986
[Clinical neurological picture of Danish patients with AIDS]F Boesen, B Brun, J Gaub, et al.
Scandinavian Journal of Infectious Diseases|November 27, 1999
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort studyS Jensen-Fangel, O Kirk, L Larsen, et al.
The Journal of Infectious Diseases|October 21, 1998
Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretionA K Iversen, L Fugger, J Eugen-Olsen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy GroupJ Gerstoft, H Melander, J N Bruun, et al.
The Journal of Infectious Diseases|May 21, 1998
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretionsA K Iversen, A R Larsen, T Jensen, et al.
AIDS (London, England)|August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNAN Clumeck, F Goebel, W Rozenbaum, et al.
Pageof 20